Viewing Study NCT01033032

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 10:02 PM

Ignite Modification Date: 2025-12-31 @ 9:04 AM

Study NCT ID: NCT01033032

Status: COMPLETED

Last Update Posted: 2022-05-03

First Post: 2009-12-15

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer

Sponsor: SCRI Development Innovations, LLC

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module